Tradjenta Tablets to Treat Type 2 Diabetes
The diabetics face difficulty in breaking down the carbohydrates as their body develops resistance against a protein, insulin, and are more likely to have a heart stroke, kidney problems, blindness and other major health complications.
The Food and Drug Administration has approved Tradjenta tablets for adults suffering from the type-2 diabetes and not able to control their blood sugar with older medicines. The type-2 is the most common form of diabetes that affects approximately, 95% of the 24 million people in the U. S. suffering from the diabetes. The medicine obstructs the DPP-4 enzyme, which secretes an insulin boosting hormone and helps to control the blood sugar levels.
Prof. Klaus Dugi, Corporate Senior Vice President Medicine, Boehringer Ingelheim, said : “Type 2 diabetes is increasing at an alarming rate and we are proud to offer people in the United States a new treatment option from our Boehringer Ingelheim research laboratories that could potentially help the millions of patients with type 2 diabetes whose blood sugar is not adequately controlled”.
The FDA has approved the medicine as a single treatment or sometimes in combination with other recommended medicines for the type 2 diabetes such as metformin, sulphonylurea and pioglitazone.
It has become an effort in futility to cast blame...Read More
The newly elected leader of the Republican Party in...Read More
On Monday this week, the French government accepted...Read More
French Prime Minister Edouard Philippe is being...Read More
A new television channel in France, RT France, Took...Read More